IP Verse

Weinzierl, Gerhard opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Weinzierl, Gerhard

Patent Number:
EP3351261
Title:
Combination Medicament Comprising Il-12 And An Agent For Blockade Of T-Cell Inhibitory Molecules For Tumour Therapy
Applicant:
UNIVERSITÄT ZÜRICH
Opposition Date:
Mar 2, 2022
Patent Number:
EP3330370
Title:
Process For Cultivation Of Cho Cells
Applicant:
NOVARTIS AG
Opposition Date:
Nov 23, 2021
Patent Number:
EP3062798
Title:
Modified Rna With Decreased Immunostimulatory Properties
Applicant:
CUREVAC AG
Opposition Date:
Feb 8, 2021
Patent Number:
EP3338794
Title:
Toxicity Management For Anti-Tumor Activity Of Cars
Applicant:
THE CHILDREN'S HOSPITAL OF PHILADELPHIA
Opposition Date:
Nov 26, 2020
Patent Number:
EP3116902
Title:
Method For Generating T-Cells Compatible For Allogenic Transplantation
Applicant:
CELLECTIS
Opposition Date:
Oct 1, 2020
Patent Number:
EP1797886
Title:
Immune Stimulation Using Chemically Modified Rna
Applicant:
CUREVAC AG
Opposition Date:
Apr 9, 2020
Patent Number:
EP2337849
Title:
Factor Ix Polypeptide Mutant, Its Uses And A Method For Its Production
Applicant:
SIMIONI, PAOLO
Opposition Date:
Mar 12, 2019
Patent Number:
EP2563906
Title:
Improved Cell Cultivation Process
Applicant:
NOVARTIS AG
Opposition Date:
Aug 8, 2018
Patent Number:
EP3013849
Title:
Purification Process For Monoclonal Antibodies
Applicant:
CADILA HEALTHCARE LIMITED
Opposition Date:
Jun 13, 2018
Patent Number:
EP2513134
Title:
Wash Solution And Method For Affinity Chromatography
Applicant:
NOVARTIS AG
Opposition Date:
Jun 6, 2018

Competitors of Weinzierl, Gerhard

NOVARTIS AG

CUREVAC AG

CADILA HEALTHCARE LIMITED

Want to track Weinzierl, Gerhard?

Feel free to send us a message here and we will get back to you